Search Penny Hill Press

Monday, April 8, 2013

Medicare Secondary Payer: Coordination of Benefits



Suzanne M. Kirchhoff
Analyst in Health Care Financing

Hinda Chaikind
Section Research Manager


Medicare is a federal program that covers medical services for qualified beneficiaries. Established in 1965 to provide health insurance to individuals age 65 and older, Medicare has been expanded to include permanently disabled individuals under 65. Medicare now consists of four parts (A-D) that cover hospitalizations, physician services, prescription drugs, skilled nursing facility care, home health visits, hospice care and other treatments. Generally, Medicare is the “primary payer” for medical services, meaning that it pays health claims first. If a beneficiary has other health insurance, that insurance is billed after Medicare has made payments, to fill all, or some, of any gaps in Medicare coverage. In certain situations, however, federal Medicare Secondary Payer (MSP) law prohibits Medicare from making payments for an item or service when payment has been made, or can reasonably be expected to be made, by another insurer such as an employersponsored group health plan. Congress initiated MSP in 1980 to ensure that certain insurers met their contractual obligations to beneficiaries and to reduce Medicare expenditures, thus extending the life of the Medicare Trust Fund. According to the Department of Health and Human Services (HHS), private insurers designated legally primary to Medicare now pay about $8 billion in claims from Medicare recipients each year.

In general, Medicare is the secondary payer for beneficiaries who are also covered through (1) a group health plan based on their own or their spouse’s current employment; (2) auto and other liability insurance; (3) no-fault liability insurance; and (4) workers’ compensation programs, including the Federal Black Lung Program. Additionally, Medicare is prohibited from covering items and services paid for directly, or indirectly, by another government entity, such as the Department of Veterans Affairs (subject to certain limitations). In cases when Medicare is the secondary payer but primary payment is delayed or in dispute—for example, a medical liability lawsuit—Medicare can step in to cover claims to ensure that beneficiaries do not experience a gap in coverage. Medicare must be reimbursed for these conditional payments when a primary insurer makes payment.

To identify cases where Medicare is the secondary payer and prevent improper Medicare payments, HHS matches information about Medicare recipients against data from the Social Security Administration and Internal Revenue Service. The Medicare, Medicaid, and SCHIP Extension Act of 2007 (P.L. 110-173) requires private insurers such as group health plans, liability insurers, no-fault insurers, and workers’ compensation plans to regularly submit coverage information to HHS regarding Medicare beneficiaries. In December 2012, Congress approved, and the President signed into law, H.R. 1845 (P.L. 112-242), which includes provisions designed to speed up the process for settling Medicare conditional claims in liability, no-fault, and similar cases. Title II of P.L. 112-242 requires HHS to establish a secure website that beneficiaries and their representatives can access to view information on conditional payments relating to a potential settlement, judgment, or award. The law made additional changes to the MSP statute and current HHS procedures, including data reporting requirements, appeal rights, use of Social Security numbers, and statutes of limitations. Separately, HHS has been attempting to create streamlined processes for settling smaller-dollar liability and workers’ compensation cases involving Medicare beneficiaries. In June 2012, HHS published a proposed rulemaking to expedite certain liability and workers’ compensation settlements that include coverage for future medical bills. This report examines the MSP system, reporting requirements, liability issues, and issues for Congress.



Date of Report: March 22, 2013
Number of Pages: 33
Order Number: RL33587
Price: $29.95

To Order:


RL33587.pdf  to use the SECURE SHOPPING CART

e-mail congress@pennyhill.com

Phone 301-253-0881

For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card number, expiration date, and name on the card. Indicate whether you want e-mail or postal delivery. Phone orders are preferred and receive priority processing.


Friday, April 5, 2013

The Foundation of the Affordable Care Act and Health Policy



A selected collection of Congressional Research Service studies expanded by Penny Hill Press through content selection and hyperlink activation.


Date of Report: April 4, 2013
Number of Pages: 409
Order Number: IC1306
Price: $28.00

To Order:


IC1306.pdf  to use the SECURE SHOPPING CART

e-mail congress@pennyhill.com

Phone 301-253-0881

For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card number, expiration date, and name on the card. Indicate whether you want e-mail or postal delivery. Phone orders are preferred and receive priority processing.

Financing and Spending of the Affordable Care Act and Health Policy



A selected collection of Congressional Research Service studies expanded by Penny Hill Press through content selection and hyperlink activation.


Date of Report: April 4, 2013
Number of Pages: 100
Order Number: IC1305
Price: $18.00

To Order:


IC1305.pdf  to use the SECURE SHOPPING CART

e-mail congress@pennyhill.com

Phone 301-253-0881

For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card number, expiration date, and name on the card. Indicate whether you want e-mail or postal delivery. Phone orders are preferred and receive priority processing.

Selected Resources on Federal Oversight of Compounding Pharmacies



Judith M. Glassgold
Specialist in Health Policy

Susan Thaul
Specialist in Drug Safety and Effectiveness

Janet Kinzer
Information Research Specialist


In September 2012, the Centers for Disease Control and Prevention (CDC), the Tennessee Department of Health, the Food and Drug Administration (FDA), and other state health departments1 began investigating a rare, non-contagious2 outbreak of fungal meningitis. As of March 4, 2013, 20 states have reported 720 infections (including fungal meningitis and other conditions) and 48 deaths.3 Patients at risk are those who received injections of contaminated, preservative-free methylprednisone acetate produced by the New England Compounding Center (NECC) after May 2012.4 On October 4, 2012, the FDA verified that NECC was the source of the contaminated products.5 

There has been extensive news coverage of the outbreak, which raised issues about the safety of compounded drugs and the role of federal and state governments in regulating compounded drugs and compounding pharmacies.
6 A number of policy questions about FDA authority and resources were raised in congressional hearings held by the Energy and Commerce Committee of the U.S. House of Representatives and the Health, Education, Labor, and Pensions Committee of the U.S. Senate.7 

This report provides selected resources on the federal government’s oversight of compounded drugs and compounding pharmacies, with an emphasis on relevant federal law and regulation and

the activities of federal agencies related to and following the 2012 fungal meningitis outbreak. Resources from three states that have direct roles in this outbreak through licensing NECC, or reporting and tracking the fungal meningitis outbreak, are included as well. After a brief background section, the selected resources presented in this report appear in the following order:8 


  • federal law; 
  • congressional hearings; 
  • proposed legislation (current and previous Congresses); 
  • congressional support agency products; 
  • FDA agency guidance and regulations, meetings, and related documents; 
  • FDA actions on drug compounding; 
  • other federal agency actions and resources; 
  • selected state resources; and 
  • articles from legal, professional, and scientific journals.


Date of Report: March 21, 2013
Number of Pages: 19
Order Number: R42837
Price: $29.95

To Order:


R42837.pdf  to use the SECURE SHOPPING CART

e-mail congress@pennyhill.com

Phone 301-253-0881

For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card number, expiration date, and name on the card. Indicate whether you want e-mail or postal delivery. Phone orders are preferred and receive priority processing.


Thursday, April 4, 2013

International Family Planning



A selected collection of Congressional Research Service studies expanded by Penny Hill Press through content selection and hyperlink activation.


Date of Report: April 3, 2013
Number of Pages: 36
Order Number: IC1303
Price: $18.00

To Order:


IC1303.pdf  to use the SECURE SHOPPING CART

e-mail congress@pennyhill.com

Phone 301-253-0881

For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card number, expiration date, and name on the card. Indicate whether you want e-mail or postal delivery. Phone orders are preferred and receive priority processing.